Shares in Biocompatibles (BII.L) rise 8.3 percent, building on gains of around 6 percent from Monday, on the back of positive cancer trials data.
"In our view, these trials add to the growing body of evidence supporting the use of drug eluting beads in HCC and mCRC," says analyst Michael Aitkenhead at Piper Jaffray in a note to clients.
Reuters messaging rm://ben.deighton.thomsonreuters.com@reuters.net
OTTAWA (Reuters) - BlackBerry maker Research In Motion reported a 58 percent jump in quarterly profit on Thursday, as sturdy demand from holiday shoppers helped fend off growing competition, sending its shares sharply higher.
"I told Michelle when we got here that in six months my poll numbers will start crashing," says President Obama. He's not worried -- yet. Full Article
The Pentagon burns through $5 million in borrowed money every hour in Afghanistan and the amount is expected to more than double once additional troops are deployed. Commentary
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
